Acute Spinal Cord Injury – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

An acute spinal cord injury (SCI) is a traumatic event that disrupts normal sensory, motor, or autonomic function, ultimately impacting a patient’s physical, psychological, and social well-being. It comprises two phases: the primary and secondary phases. The primary phase involves the initial mechanical damage to the spinal cord, typically caused by spine deformation, direct compression, and neural element or blood vessel damage due to fractured or displaced bone fragments or disc material. The primary injury triggers the secondary phase and encompasses a series of biochemical and cellular processes, including electrolyte imbalances, the generation of free radicals, vascular ischemia, edema, posttraumatic inflammatory reactions, apoptosis, and other cellular responses.
Healthcare providers categorize SCIs into two types based on symptoms:
• Complete injury: Characterized by a lack of movement or sensation below the injury point.
• Incomplete injury: Where there is still some sensation or movement below the injury point.
Risk factors for SCI include:
• Individuals in the age range of 16-30 are at a higher risk of traumatic spinal injury.
• Statistics indicate that men are disproportionately more susceptible to spinal cord injuries.
• People over 65 are prone to spinal cord damage from falls.
• Pre-existing bone or joint disorders like osteoporosis or arthritis can increase susceptibility to spinal injuries.
• Engaging in risky behaviors such as diving into shallow waters or participating in sports without adequate protective gear can lead to spinal injuries.
In the United States, approximately 17,000 new cases of SCI occur each year, with an estimated 282,000 people living with SCI. The majority of SCI cases related to sports injuries involve males.

Thelansis’s “Acute Spinal Cord Injury Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Spinal Cord Injury treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Acute Spinal Cord Injury across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Acute Spinal Cord Injury Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Acute Spinal Cord Injury – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033